Fulminant amebic colitis with fatal outcome in a patient with probable SARS-CoV-2 infection
DOI:
https://doi.org/10.17843/rpmesp.2021.383.8050Keywords:
Amebiasis, COVID-19, SARS-CoV-2, Corticosteroides, Amebic Colitis, ParasitesAbstract
We report the case of a 62-year-old male with cough and abdominal pain for two weeks, associated with pulmonary tomographic findings compatible with probable infection by SARS-CoV-2, and who received high doses of early corticotherapy as an outpatient. The patient showed clinical deterioration, was hospitalized and died in the immediate postoperative period due to acute surgical abdomen. The anatomopathological study showed parasitic structures with characteristics compatible with amebae, which was pointed to as the cause of a complicated acute fulminant colitis, with multiple perforations and acute peritonitis. Acute fulminant colitis due to intestinal amebiasis in the context of a patient with probable COVID-19 had not been previously reported in Peru. It is important to highlight the fulminant presentation with fatal outcome of this prevalent parasitic infection, in the context of corticosteroids use in a probable SARS-CoV-2 pulmonary infection.Downloads
Download data is not yet available.
Downloads
Published
2021-09-30
Issue
Section
Case Report
License
Copyright (c) 2021 Revista Peruana de Medicina Experimental y Salud Pública
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
1.
Somocurcio J, Ayquipa T, Pineda V. Fulminant amebic colitis with fatal outcome in a patient with probable SARS-CoV-2 infection. Rev Peru Med Exp Salud Publica [Internet]. 2021 Sep. 30 [cited 2024 Dec. 25];38(3):458-62. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/8050